Pharmacy Onesource, Inc.

Pharmacy Onesource, Inc., a foreign-owned, for-profit subsidiary of Wolters Kluwer, delivers pharmacy management software and automation platforms to federal healthcare agencies as a prime contractor, with recent awards concentrated in the Department of Veterans Affairs across multiple Veterans Integrated Service Networks and the Defense Health Agency. The company competes full-and-open with no set-aside designations across all recent federal work.

Pharmacy Onesource's core capability is the SIMPLIFI 797 medication workflow automation platform, a comprehensive pharmacy compliance and inventory management system supporting USP 795 and 800 sterile compounding, hazardous drug handling, quality control, and medication tracking. The vendor also delivers related modules including Critical Point for hazardous drug handling oversight, SIMPLIFI+ MedStorage and MedTrays for automated medication storage and crash-cart replenishment, and continuing education pharmacy compounding subscriptions for USP compliance. Recent representative work includes a $611,731 delivery order from VA Technology Acquisition Center for SIMPLIFI+ MedTrays with implementation services (awarded October 2025); a $479,121 delivery order from VA Technology Acquisition Center for SIMPLIFI 797 with Critical Point and USP 800 modules (awarded October 2023); a $355,858 delivery order for USP Compliance Monitoring services from the Department of Veterans Affairs (awarded June 2025); and a $166,528 delivery order from NIH Clinical Center for SIMPLIFI 797 subscription renewal (awarded December 2021). Place of performance is predominantly Madison, Wisconsin, with secondary sites in Bethesda, Maryland, Waltham, Massachusetts, and other VA facility locations.

Customer concentration is dominated by the VA system. The top five funding agencies by award count account for 59% of recent awards, led by the Department of the Army Medical Command (101 awards, $1.3 million combined potential value) and the Department of the Navy Bureau of Medicine and Surgery (47 awards, $665 thousand). Within the VA, Veterans Integrated Service Network 4 leads at 26 awards ($783 thousand combined potential value), followed by VISN 20 (18 awards, $456 thousand) and VISN 1 (17 awards, $2.8 million). By potential-value concentration, however, the VA Technology Acquisition Center anchors the footprint at $3.7 million across six awards, with VISN 1 at $2.8 million and VISN 10 at $1.9 million. This ranking divergence reflects the Technology Acquisition Center's role in issuing higher-value enterprise-level platform renewals while individual VISNs issue numerous smaller subscription and module task orders.

Pharmacy Onesource holds positions on two primary vehicle platforms. The Federal Supply Schedule (GSA GS35F0571S) anchors 148 task orders carrying $3.2 million combined potential value, and the Multiple Award Schedule (MAS) carries 82 task orders worth $10.7 million combined potential value. The vendor also operates under multiple Blanket Purchase Agreements with the VA, including a $2.1 million BPA supporting VISNs 1 and 4 for SIMPLIFI 797 and related modules, a $350,000 BPA with VISN 22 for pharmaceutical compounding software, and an $800,000 MAS contract cited across multiple VISN delivery orders. A single-award indefinite-delivery contract with VISN 10 valued at $870,353 (awarded September 2025) is structured through September 2027 with four option years, supporting pharmacy sterile compounding documentation across Indiana, Ohio, and Michigan facilities.

Activity has grown modestly but steadily year over year—11 awards in 2022 to 26 in 2025—indicating stable market traction within VA and defense health networks. Nine awards (combined potential value $1.5 million) reach ultimate completion within the next twenty-four months, creating modest recompete exposure. The combined potential value across all 356 prime awards is $23.3 million, with $12 million obligated to date (52% realization rate).

Pharmacy Onesource operates exclusively as a prime contractor (100% of awards); the SCI dataset shows no sub-engagement and no named subcontractors across the award portfolio. SCI-reportable invoicing totaled $250 thousand in FY2025 and $197 thousand in FY2024, with zero FTE trajectory reported across all fiscal years in the SCI dataset—a signal that most Pharmacy Onesource work consists of software licenses, subscriptions, and SaaS deliverables rather than billable labor. The vendor does not subcontract or rely on subcontractor delivery; it is a pure software and platform vendor operating on its own delivery model.

The award footprint is categorized primarily under NAICS 513210 (Software Publishers, 149 awards) and Other Computer Related Services (160 awards), with secondary presence in Custom Computer Programming Services (17 awards). PSC coding aligns to Information Technology Software (125 awards), Business Application Software as SaaS (15 awards), and Medical/Surgical Equipment and Supplies (27 awards), reflecting the healthcare automation dimension of the SIMPLIFI platform.